Related Experiment Video
Updated: Aug 24, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53
Patricia Stanhope-Baker1, Patricia M Kessler, Wenliang Li
1Departments of Cancer Biology and Molecular Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Abstract:
Wilms tumors are a heterogeneous class of tumors in which Wilms tumor suppressor-1 (WT1) and the p53 tumor suppressor may be variously inactivated by mutation, reduced in expression, or even overexpressed in the wild-type state. The downstream transcriptional targets of WT1 and p53 that are critical for mediating their roles in Wilms tumorigenesis are not well defined. The WiT49 cell line is characteristic of anaplastic Wilms tumors that are refractory to treatment and expresses wild-type WT1 and mutant p53. We have used the small molecule compound CP-31398 (Pfizer) to restore wild-type p53 function to the codon 248 mutant p53 present in WiT49 cells. In these cells, CP-31398 activated transcription of p53-regulated promoters and enhanced UV light-induced apoptosis without altering the overall p53 protein level. These phenotypes were accompanied by restored binding of the p53 protein to promoter sequences in vivo. Gene expression profiling of CP-31398-treated WiT49 cells revealed subsets of putative p53 target genes that were up- or down-regulated. A preferred target of p53-mediated repression in this system is the podocalyxin (PODXL) gene. PODXL is also transcriptionally regulated by WT1 and has roles in cell adhesion and anti-adhesion. Our results show that PODXL is a bona fide target of p53-mediated transcriptional repression while being positively regulated by WT1. We propose that inappropriate expression of PODXL due to changes in WT1 and/or p53 activity may contribute to Wilms tumorigenesis.
Insights
Restoring wild-type p53 function in Wilms tumor cells with CP-31398 activated p53 targets and repressed podocalyxin (PODXL). This suggests PODXL
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Wilms tumors exhibit diverse genetic alterations affecting tumor suppressors like WT1 and p53.
- The specific downstream targets of WT1 and p53 in Wilms tumorigenesis remain largely undefined.
- The anaplastic Wilms tumor cell line WiT49 harbors wild-type WT1 and mutant p53, and is treatment-refractory.
Purpose of the Study:
- To investigate the functional restoration of mutant p53 in WiT49 cells using the small molecule CP-31398.
- To identify p53-regulated genes involved in Wilms tumorigenesis.
- To elucidate the regulatory relationship between WT1, p53, and the podocalyxin (PODXL) gene.
Main Methods:
- Utilized the small molecule CP-31398 to restore wild-type p53 function in WiT49 cells.
- Assessed p53-regulated promoter activity and UV-induced apoptosis.
- Performed gene expression profiling to identify p53 target genes.
- Investigated the in vivo binding of p53 to promoter sequences.
Main Results:
- CP-31398 treatment reactivated p53-regulated transcription and enhanced UV-induced apoptosis in WiT49 cells.
- Restored p53 binding to target gene promoters in vivo.
- Gene expression profiling identified genes up- or down-regulated by p53.
- Podocalyxin (PODXL) was identified as a key target gene repressed by p53 and positively regulated by WT1.
Conclusions:
- CP-31398 effectively restores wild-type p53 activity in a mutant p53 Wilms tumor cell line.
- PODXL is a direct transcriptional target of p53-mediated repression and WT1-mediated activation.
- Aberrant PODXL expression, driven by altered WT1 and p53 pathways, may contribute to Wilms tumor development.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
